Skip to content

Effect of rScO2-oriented hemodynamic management on postoperative complications in elderly patients after major noncardiac surgery: a randomized controlled trial

Effect of rScO2-oriented hemodynamic management on postoperative complications in elderly patients after major noncardiac surgery: a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200060816
Enrollment
Unknown
Registered
2022-06-12
Start date
2022-07-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effect of rScO2-oriented hemodynamic management in elderly patients after major noncardiac surgery

Interventions

Intervention group:With an rScO2-oriented hemodynamic management strategy, the target is to maintain rScO2 =90% of the baseline value and MAP =65 mmHg or within ± 20% of the baseline value using vasop
Control group:Through invasive hemodynamic monitoring, the target is to maintain MAP =65 mmHg or within ± 20% of the baseline value using vasopressors.

Sponsors

Department of Anesthesiology, The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.Adult patients aged 60-90 years; 2.Major noncardiac surgery planned under general anesthesia; 3.ASA classification II or III; 4.An estimated surgical duration of 2 hours or more.

Exclusion criteria

Exclusion criteria: 1. Emergency surgery; 2. Spinal and/or epidural anesthesia; 3. Severe untreated or uncontrolled hypertension with systolic blood pressure (SBP) >= 180 mm Hg or diastolic blood pressure (DBP) >= 110 mm Hg despite medication; 4. Preoperative acute cardiovascular events, including acute or decompensated heart failure and acute coronary syndrome; 5. Acute phase of cerebrovascular disease or cerebrovascular accident; 6. Liver insufficiency (Child-Pugh grade >= B); 7. Chronic kidney disease with creatinine >= 200µmol/L or end-stage renal disease requiring renal replacement therapy; 8. Preoperative sepsis; 9. Refuse to participate.

Design outcomes

Secondary

MeasureTime frame
Mortality and incidence of complications within 30 days after surgery;

Primary

MeasureTime frame
Incidence of major complications within the first 7 days after surgery;

Countries

China

Contacts

Public ContactFuhai JI

The First Affiliated Hospital of Soochow University

jifuhai@hotmail.com+86 13656207331

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026